Y200-5345 Screening compound: 4-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-2-methyl-1-(4-methylphenyl)piperazine

Y200-5345 Screening compound: 4-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-2-methyl-1-(4-methylphenyl)piperazine
Y200-5345 Screening compound: 4-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-2-methyl-1-(4-methylphenyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-5345
4-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-2-methyl-1-(4-methylphenyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-5345

Molecular Formula

C23H23ClFN3O2 (C23 H23 ClFN3 O2)

Compound Name

4-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-2-methyl-1-(4-methylphenyl)piperazine

IUPAC name

4-[3-(2-chloro-6-fluorophenyl)-5-methyl-12-oxazole-4-carbonyl]-2-methyl-1-(4-methylphenyl)piperazine

SMILES

CC(CN(CC1)C(c2c(C)onc2-c(c(F)ccc2)c2Cl)=O)N1c1ccc(C)cc1

InChI

InChI=1S/C23H23ClFN3O2/c1-14-7-9-17(10-8-14)28-12-11-27(13-15(28)2)23(29)20-16(3)30-26-22(20)21-18(24)5-4-6-19(21)25/h4-10,15H,11-13H2,1-3H3/t15-/m0/s1

InChI Key

FBHSGVSCDBBWIV-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD02245151

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.91

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.396

Distribution Coefficient, logD

4.396

Water Solubility, LogSw

-4.75

Polar Surface Area

41.326

Acid Dissociation Constant (pKa)

26.03

Base Dissociation Constant (pKb)

6.70

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.40

Y200-5345 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with Y200-5345 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-5345?
Check Price and Availability of Y200-5345, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-5345 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-5345
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-5345
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-5345 available by request